LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER

Clinical trials for LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug combo shows promise against tough breast cancer

Disease control Not yet recruiting

This study tests whether adding the experimental drug BEBT-209 to standard chemotherapy (carboplatin and gemcitabine) works better than chemotherapy alone for people with advanced triple-negative breast cancer. About 446 women aged 18-75 will be randomly assigned to one of two gr…

Matched conditions: LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER

Phase: PHASE2, PHASE3 • Sponsor: BeBetter Med Inc • Aim: Disease control

Last updated May 17, 2026 13:02 UTC

LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER

Get alerted when new LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER trials appear

New drug combo shows promise against tough breast cancer